🆚 Emacs vs. MSHTML
MSHTML is much more popular than Emacs.- MSHTML is more popular in all countries.
Statistics based on 4M+ analyzed websites. About this data
EmacsType
HTML editor
HTML editor
About
Emacs is a fully programmable text editor available for most modern operating systems.
MSHTML is an editor based on the MSHTML component of the discontinued Internet Explorer browser.
Headquarters
Boston, Massachusetts, United States
Redmond, Washington, United States
gnu.org
TridentPricing
Free ✔️ Open source
Categories
Popularity
Determined by the number of sites using each technology.
MSHTML technology is 87 times more popular than Emacs.
Total websites
Market share
HTML Editors
Popularity by country
Determined by the number of sites detected from each country.
MSHTML is more popular than Emacs in all countries.
United States
China
Japan
United Kingdom
Canada
Germany
Russia
Italy
France
India
Awards
- 🥈 Second most popular in China in the HTML Editors category.
- 🥉 Third most popular in the United Kingdom in the HTML Editors category.
- 🥉 Third most popular in Canada in the HTML Editors category.
- 🔥 14th most popular in China in the Legacy category.
- ⬆️ 42nd most popular in Canada in the Legacy category.
Popularity by domain category
Determined by the number of sites in each category.
MSHTML is more popular than Emacs in all market segments.
Business
Education/Reference
Marketing/Merchandising
Online Shopping
Entertainment
Health
Art/Culture/Heritage
Internet Services
Travel
Public Information
Top sites
Top-ranked sites that use these technologies.
Compare alternatives
Technologies with similar characteristics.
Free Software Foundation company profile🗃️ About This Data
- We evaluate the popularity of technologies based on the number of websites where we detect their usage.
- Technologies without a detectable web footprint, and those we do not track, are not reflected in the calculated market share.
- This report is based on the analysis of 4,046,631 websites.
- Statistics were last calculated on .
- For more details, see our methodology and disclaimer.